Citations available for content in Chicago, APA and MLA format.
Citations are generated automatically from bibliographic data as a convenience and may not be complete or accurate.
Notice. "NIST Consortium for Advancement of Genome Editing" Federal Register 89, no. 205 (October 23, 2024): 84534. https://www.govinfo.gov/app/details/FR-2024-10-23/2024-24514.
Office of the Federal Register, National Archives and Records Administration. (). 89 FR 84534 - NIST Consortium for Advancement of Genome Editing. [Government]. Office of the Federal Register, National Archives and Records Administration. https://www.govinfo.gov/app/details/FR-2024-10-23/2024-24514
Office of the Federal Register, National Archives and Records Administration. 89 FR 84534 - NIST Consortium for Advancement of Genome Editing. Office of the Federal Register, National Archives and Records Administration, , https://www.govinfo.gov/app/details/FR-2024-10-23/2024-24514
Office of the Federal Register, National Archives and Records Administration, NIST Consortium for Advancement of Genome Editing, govinfo, (October 23, 2024), https://www.govinfo.gov/app/details/FR-2024-10-23/2024-24514.
Close xFederal Register Volume 89, Issue 205 (October 23, 2024)
Regulatory Information
Federal Register
AE 2.7:
GS 4.107:
AE 2.106:
Office of the Federal Register, National Archives and Records Administration
Notices
Notice of Research Consortium; Extension of Research Consortium.
The Consortium's activities will continue as needed to complete the updated research plan. NIST will accept letters of interest to participate in this Consortium on an ongoing basis. Acceptance of participants into the Consortium will depend on the availability of resources.
The National Institute of Standards and Technology (NIST) extends the duration of the NIST Consortium for Advancement of Genome Editing (Genome Editing Consortium or Consortium). The Consortium duration was previously through December 1, 2025. NIST is taking this action to provide additional time for interested parties to join the Consortium to further pursue the implementation and achievement of outcomes of the current Consortium activities, as well as to address additional standards needs as defined by the Consortium in qualification of off-target assays and quality of genome editing components. Beginning January 1, 2026 participation fees will increase to $25,000 annually or in-kind contributions of equivalent value. Participants will be required to sign a Cooperative Research and Development Agreement (CRADA).
DEPARTMENT OF COMMERCE
National Institute of Standards and Technology
84534-84534
89 FR 84534
2024-24514